{"filing":{"accession_number":"0001728117-26-000057","cik":"0001728117","ticker":"GOSS","company_name":"Gossamer Bio, Inc.","form":"8-K","filing_date":"2026-07-01","report_date":null,"primary_document":"goss-20260701.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1728117/000172811726000057/goss-20260701.htm"},"events":[{"id":15360,"run_id":13705,"accession_number":"0001728117-26-000057","anchor_item_number":"7.01","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"summary":"The disclosure announces the determination of conversion rates and exercise prices for previously issued 7.50% Convertible Senior Secured First Lien Notes due 2030 and associated Purchase Warrants. While this is a technical calculation event rather than the initial issuance, it relates to the terms and mechanics of a material debt obligation and represents a significant capital structure event. The conversion price of $0.19 per share and warrant exercise price of $0.34 per share are material terms that affect shareholder dilution and the company's capital structure.","company_name":"Gossamer Bio, Inc.","ticker":"GOSS","filing_date":"2026-07-01","form":"8-K","submitted_at":null,"items":[{"id":13090,"accession_number":"0001728117-26-000057","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The disclosure announces the determination of conversion rates and exercise prices for previously issued 7.50% Convertible Senior Secured First Lien Notes due 2030 and associated Purchase Warrants. While this is a technical calculation event rather than the initial issuance, it relates to the terms and mechanics of a material debt obligation and represents a significant capital structure event. The conversion price of $0.19 per share and warrant exercise price of $0.34 per share are material terms that affect shareholder dilution and the company's capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-01T13:02:13.547774+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":13090,"accession_number":"0001728117-26-000057","item_number":"7.01","item_title":"Regulation FD Disclosure.","event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"The disclosure announces the determination of conversion rates and exercise prices for previously issued 7.50% Convertible Senior Secured First Lien Notes due 2030 and associated Purchase Warrants. While this is a technical calculation event rather than the initial issuance, it relates to the terms and mechanics of a material debt obligation and represents a significant capital structure event. The conversion price of $0.19 per share and warrant exercise price of $0.34 per share are material terms that affect shareholder dilution and the company's capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-01T13:02:13.547774+00:00","company_name":"Gossamer Bio, Inc.","ticker":"GOSS","filing_date":"2026-07-01"}]}